Cargando…

CD8 T Cell–Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas

Malignant brain tumors continue to represent a devastating diagnosis with no real chance for cure. Despite an increasing list of potential salvage therapies, standard-of-care for these patients has not changed in over a decade. Immunotherapy has been seen as an exciting option, with the potential to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murphy, Katherine A., Griffith, Thomas S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999780/ https://www.ncbi.nlm.nih.gov/pubmed/27472363 http://dx.doi.org/10.3390/cancers8080071

Ejemplares similares

Host type I IFN signals are required for antitumor CD8(+) T cell responses through CD8α(+) dendritic cells
por: Fuertes, Mercedes B., et al.
Publicado: (2011)

Antitumor effect of lenalidomide in malignant glioma cell lines
por: Hanashima, Yuya, et al.
Publicado: (2020)

Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8(+) T-cell responses and immune memory
por: Wu, Junjie, et al.
Publicado: (2015)

Antitumor Activity of TRAIL Recombinant Adenovirus in Human Malignant Glioma Cells
por: Kim, Ki-Uk, et al.
Publicado: (2005)

Antitumor effect of fibrin glue containing temozolomide against malignant glioma
por: Anai, Shigeo, et al.
Publicado: (2014)

Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response
por: Reiser, John, et al.
Publicado: (2016)

Helper cell-independent antitumor activity of potent CD8(+) T cell epitope peptide vaccines is dependent upon CD40L
por: Llopiz, Diana, et al.
Publicado: (2013)

Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8(+) T Cells
por: Chowdhury, Snehanshu, et al.
Publicado: (2022)

Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cells
por: Ochiai, Yushi, et al.
Publicado: (2020)

Hypoxia and antitumor CD8(+) T cells: An incompatible alliance?
por: Vuillefroy de Silly, Romain, et al.
Publicado: (2016)

Self-antigen–specific CD8(+) T cell precursor frequency determines the quality of the antitumor immune response
por: Rizzuto, Gabrielle A., et al.
Publicado: (2009)

Impact of epigenetic reprogramming on antitumor immune responses in glioma
por: McClellan, Brandon L., et al.
Publicado: (2023)

Malignant Glioma Therapy by Vaccination with Irradiated C6 Cell-Derived Microvesicles Promotes an Antitumoral Immune Response
por: Pineda, Benjamín, et al.
Publicado: (2019)

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response
por: Ercolini, Anne M., et al.
Publicado: (2005)

Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity
por: Shah, Sabaria, et al.
Publicado: (2023)

Interleukin-27 potentiates CD8(+) T-cell-mediated antitumor immunity in chronic lymphocytic leukemia
por: Pagano, Giulia, et al.
Publicado: (2023)

Anti-tumour activity of deer growing antlers and its potential applications in the treatment of malignant gliomas
por: Chonco, Louis, et al.
Publicado: (2021)

Therapeutic potential of pentamidine for glioma‐initiating cells and glioma cells through multimodal antitumor effects
por: Tamai, Sho, et al.
Publicado: (2023)

Regulation of CD8(+) T Cells and Antitumor Immunity by Notch Signaling
por: Tsukumo, Shin-ichi, et al.
Publicado: (2018)

Creatine uptake regulates CD8 T cell antitumor immunity
por: Di Biase, Stefano, et al.
Publicado: (2019)

CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

Bystander memory CD8 T cell proliferation after anti-CD40/IL-2 treatment is independent of CD4 T cells
por: Grossenbacher, Steven K, et al.
Publicado: (2013)

Potential Role of Carbon Nanomaterials in the Treatment of Malignant Brain Gliomas
por: Caffo, Maria, et al.
Publicado: (2023)

Suppression of Immunodominant Antitumor and Antiviral CD8(+) T Cell Responses by Indoleamine 2,3-Dioxygenase
por: Rytelewski, Mateusz, et al.
Publicado: (2014)

T-cell modulatory properties of CD5 and its role in antitumor immune responses
por: Tabbekh, Mouna, et al.
Publicado: (2013)

CD8α+ dendritic cells potentiate antitumor and immune activities against murine ovarian cancers
por: Lee, Shin-Wha, et al.
Publicado: (2023)

Antitumor effect of a new nano-vector with miRNA-135a on malignant glioma
por: Liang, Chaofeng, et al.
Publicado: (2017)

Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies
por: Lin, Shouheng, et al.
Publicado: (2021)

Glioma Stem Cells and Immunotherapy for the Treatment of Malignant Gliomas
por: Toda, Masahiro
Publicado: (2013)

Embryonic Fibroblasts Promote Antitumor Cytotoxic Effects of CD8(+) T Cells
por: Qin, Yingyu, et al.
Publicado: (2018)

Reinforce the antitumor activity of CD8(+) T cells via glutamine restriction
por: Nabe, Shogo, et al.
Publicado: (2018)

CXCR6 is required for antitumor efficacy of intratumoral CD8(+) T cell
por: Wang, Binglin, et al.
Publicado: (2021)

Ezh2 phosphorylation state determines its capacity to maintain CD8(+) T memory precursors for antitumor immunity
por: He, Shan, et al.
Publicado: (2017)

Thioredoxin Reductase Inhibitors as Potential Antitumors: Mercury Compounds Efficacy in Glioma Cells
por: Pires, Vanessa, et al.
Publicado: (2022)

Antitumor Effect of a New Nano-Vector with miRNA-135a on Malignant Glioma [Corrigendum]
Publicado: (2020)

The potential roles of aquaporin 4 in malignant gliomas
por: Lan, Yu-Long, et al.
Publicado: (2017)

Autophagy as a Potential Therapy for Malignant Glioma
por: Escamilla-Ramírez, Angel, et al.
Publicado: (2020)

Potential Therapeutic Effects of Thiazolidinedione on Malignant Glioma
por: Sheu, Meei-Ling, et al.
Publicado: (2022)

CD8(+) T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma
por: Xu, Chun, et al.
Publicado: (2018)

EOMES is essential for antitumor activity of CD8(+) T cells in chronic lymphocytic leukemia
por: Llaó-Cid, Laura, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5rkkjkt2r493uq6houb9tcgndd